ClearBridge Investments
BMRN icon

ClearBridge Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-197,518
Closed -$14M 712
2025
Q1
$14M Sell
197,518
-12,736
-6% -$900K 0.01% 448
2024
Q4
$13.8M Sell
210,254
-35,140
-14% -$2.31M 0.01% 487
2024
Q3
$17.2M Sell
245,394
-14,179
-5% -$997K 0.01% 467
2024
Q2
$21.4M Sell
259,573
-1,529
-0.6% -$126K 0.02% 441
2024
Q1
$22.8M Sell
261,102
-9,741
-4% -$851K 0.02% 442
2023
Q4
$26.1M Sell
270,843
-160,576
-37% -$15.5M 0.02% 432
2023
Q3
$38.2M Sell
431,419
-1,758
-0.4% -$156K 0.04% 344
2023
Q2
$37.5M Sell
433,177
-37,906
-8% -$3.29M 0.03% 359
2023
Q1
$45.8M Sell
471,083
-631,206
-57% -$61.4M 0.04% 331
2022
Q4
$114M Sell
1,102,289
-71,414
-6% -$7.39M 0.11% 186
2022
Q3
$99.5M Buy
1,173,703
+48,615
+4% +$4.12M 0.1% 192
2022
Q2
$93.2M Sell
1,125,088
-984,288
-47% -$81.6M 0.09% 220
2022
Q1
$163M Sell
2,109,376
-3,154,216
-60% -$243M 0.12% 165
2021
Q4
$465M Buy
5,263,592
+74,239
+1% +$6.56M 0.32% 86
2021
Q3
$401M Buy
5,189,353
+118,050
+2% +$9.12M 0.29% 91
2021
Q2
$423M Buy
5,071,303
+67,333
+1% +$5.62M 0.29% 88
2021
Q1
$378M Sell
5,003,970
-1,018,442
-17% -$76.9M 0.28% 90
2020
Q4
$528M Sell
6,022,412
-149,916
-2% -$13.1M 0.41% 66
2020
Q3
$470M Buy
6,172,328
+262,570
+4% +$20M 0.4% 64
2020
Q2
$729M Sell
5,909,758
-403,944
-6% -$49.8M 0.66% 36
2020
Q1
$534M Buy
6,313,702
+115,236
+2% +$9.74M 0.58% 50
2019
Q4
$521M Buy
6,198,466
+155,752
+3% +$13.1M 0.43% 67
2019
Q3
$407M Buy
6,042,714
+68,440
+1% +$4.61M 0.36% 80
2019
Q2
$512M Buy
5,974,274
+968,956
+19% +$83M 0.44% 70
2019
Q1
$445M Buy
5,005,318
+499,656
+11% +$44.4M 0.39% 84
2018
Q4
$384M Buy
4,505,662
+455,271
+11% +$38.8M 0.39% 81
2018
Q3
$393M Buy
4,050,391
+378,902
+10% +$36.7M 0.34% 91
2018
Q2
$346M Buy
3,671,489
+2,253,624
+159% +$212M 0.28% 106
2018
Q1
$115M Buy
1,417,865
+70,699
+5% +$5.73M 0.11% 177
2017
Q4
$120M Sell
1,347,166
-43,724
-3% -$3.9M 0.11% 185
2017
Q3
$129M Buy
1,390,890
+35,068
+3% +$3.26M 0.12% 167
2017
Q2
$123M Buy
1,355,822
+22,864
+2% +$2.08M 0.12% 170
2017
Q1
$117M Buy
1,332,958
+516,663
+63% +$45.4M 0.12% 176
2016
Q4
$67.6M Buy
816,295
+90,850
+13% +$7.53M 0.07% 224
2016
Q3
$67.1M Buy
725,445
+76,405
+12% +$7.07M 0.08% 220
2016
Q2
$50.5M Buy
649,040
+13,233
+2% +$1.03M 0.06% 264
2016
Q1
$52.4M Buy
635,807
+66,546
+12% +$5.49M 0.06% 254
2015
Q4
$59.6M Sell
569,261
-59,607
-9% -$6.24M 0.07% 242
2015
Q3
$66.2M Sell
628,868
-20,363
-3% -$2.14M 0.08% 229
2015
Q2
$88.8M Buy
649,231
+60,790
+10% +$8.31M 0.09% 201
2015
Q1
$73.3M Sell
588,441
-110,949
-16% -$13.8M 0.08% 234
2014
Q4
$63.2M Sell
699,390
-62,435
-8% -$5.64M 0.07% 257
2014
Q3
$55M Sell
761,825
-4,259
-0.6% -$307K 0.06% 279
2014
Q2
$47.7M Sell
766,084
-4,323
-0.6% -$269K 0.05% 298
2014
Q1
$52.5M Sell
770,407
-35,749
-4% -$2.44M 0.06% 269
2013
Q4
$56.7M Buy
806,156
+97,758
+14% +$6.88M 0.07% 259
2013
Q3
$51.1M Buy
708,398
+260,052
+58% +$18.8M 0.07% 260
2013
Q2
$25M Buy
+448,346
New +$25M 0.04% 351